530 related articles for article (PubMed ID: 19594762)
1. Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential.
Mony L; Kew JN; Gunthorpe MJ; Paoletti P
Br J Pharmacol; 2009 Aug; 157(8):1301-17. PubMed ID: 19594762
[TBL] [Abstract][Full Text] [Related]
2. Use of trifluoroperazine isolates a [(3)H]Ifenprodil binding site in rat brain membranes with the pharmacology of the voltage-independent ifenprodil site on N-methyl-D-aspartate receptors containing NR2B subunits.
Coughenour LL; Barr BM
J Pharmacol Exp Ther; 2001 Jan; 296(1):150-9. PubMed ID: 11123375
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of NR2B-selective antagonist recognition by N-methyl-D-aspartate receptors.
Mony L; Krzaczkowski L; Leonetti M; Le Goff A; Alarcon K; Neyton J; Bertrand HO; Acher F; Paoletti P
Mol Pharmacol; 2009 Jan; 75(1):60-74. PubMed ID: 18923063
[TBL] [Abstract][Full Text] [Related]
4. NMDA receptor subunits: function and pharmacology.
Paoletti P; Neyton J
Curr Opin Pharmacol; 2007 Feb; 7(1):39-47. PubMed ID: 17088105
[TBL] [Abstract][Full Text] [Related]
5. Positive Allosteric Modulation as a Potential Therapeutic Strategy in Anti-NMDA Receptor Encephalitis.
Warikoo N; Brunwasser SJ; Benz A; Shu HJ; Paul SM; Lewis M; Doherty J; Quirk M; Piccio L; Zorumski CF; Day GS; Mennerick S
J Neurosci; 2018 Mar; 38(13):3218-3229. PubMed ID: 29476014
[No Abstract] [Full Text] [Related]
6. Allosteric modulators of NMDA receptors: multiple sites and mechanisms.
Zhu S; Paoletti P
Curr Opin Pharmacol; 2015 Feb; 20():14-23. PubMed ID: 25462287
[TBL] [Abstract][Full Text] [Related]
7. Distinct GluN1 and GluN2 Structural Determinants for Subunit-Selective Positive Allosteric Modulation of
Strong KL; Epplin MP; Ogden KK; Burger PB; Kaiser TM; Wilding TJ; Kusumoto H; Camp CR; Shaulsky G; Bhattacharya S; Perszyk RE; Menaldino DS; McDaniel MJ; Zhang J; Le P; Banke TG; Hansen KB; Huettner JE; Liotta DC; Traynelis SF
ACS Chem Neurosci; 2021 Jan; 12(1):79-98. PubMed ID: 33326224
[No Abstract] [Full Text] [Related]
8. Mechanism of differential control of NMDA receptor activity by NR2 subunits.
Gielen M; Siegler Retchless B; Mony L; Johnson JW; Paoletti P
Nature; 2009 Jun; 459(7247):703-7. PubMed ID: 19404260
[TBL] [Abstract][Full Text] [Related]
9. Hippocampal long-term synaptic plasticity and signal amplification of NMDA receptors.
MacDonald JF; Jackson MF; Beazely MA
Crit Rev Neurobiol; 2006; 18(1-2):71-84. PubMed ID: 17725510
[TBL] [Abstract][Full Text] [Related]
10. Functional contributions of synaptically localized NR2B subunits of the NMDA receptor to synaptic transmission and long-term potentiation in the adult mouse CNS.
Miwa H; Fukaya M; Watabe AM; Watanabe M; Manabe T
J Physiol; 2008 May; 586(10):2539-50. PubMed ID: 18372311
[TBL] [Abstract][Full Text] [Related]
11. Chimeric Glutamate Receptor Subunits Reveal the Transmembrane Domain Is Sufficient for NMDA Receptor Pore Properties but Some Positive Allosteric Modulators Require Additional Domains.
Wilding TJ; Lopez MN; Huettner JE
J Neurosci; 2016 Aug; 36(34):8815-25. PubMed ID: 27559165
[TBL] [Abstract][Full Text] [Related]
12. Involvement of synaptic NR2B-containing NMDA receptors in long-term depression induction in the young rat visual cortex in vitro.
Li YH; Wang J; Zhang G
Chin J Physiol; 2011 Jun; 54(3):190-5. PubMed ID: 21789901
[TBL] [Abstract][Full Text] [Related]
13. Extracellular mild acidosis decreases the Ca
Plutino S; Sciaccaluga M; Fucile S
Cell Calcium; 2019 Jun; 80():63-70. PubMed ID: 30978540
[TBL] [Abstract][Full Text] [Related]
14. Positive allosteric modulation of NMDA receptors: mechanisms, physiological impact and therapeutic potential.
Geoffroy C; Paoletti P; Mony L
J Physiol; 2022 Jan; 600(2):233-259. PubMed ID: 34339523
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the structural requirements for N-methyl-D-aspartate receptor positive and negative allosteric modulators based on 2-naphthoic acid.
Irvine MW; Fang G; Sapkota K; Burnell ES; Volianskis A; Costa BM; Culley G; Collingridge GL; Monaghan DT; Jane DE
Eur J Med Chem; 2019 Feb; 164():471-498. PubMed ID: 30622023
[TBL] [Abstract][Full Text] [Related]
16. Histamine potentiates N-methyl-D-aspartate receptors by interacting with an allosteric site distinct from the polyamine binding site.
Burban A; Faucard R; Armand V; Bayard C; Vorobjev V; Arrang JM
J Pharmacol Exp Ther; 2010 Mar; 332(3):912-21. PubMed ID: 20008958
[TBL] [Abstract][Full Text] [Related]
17. The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors.
Paul SM; Doherty JJ; Robichaud AJ; Belfort GM; Chow BY; Hammond RS; Crawford DC; Linsenbardt AJ; Shu HJ; Izumi Y; Mennerick SJ; Zorumski CF
J Neurosci; 2013 Oct; 33(44):17290-300. PubMed ID: 24174662
[TBL] [Abstract][Full Text] [Related]
18. The chemical biology of clinically tolerated NMDA receptor antagonists.
Chen HS; Lipton SA
J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity of N-methyl-D-aspartate receptor-mediated excitatory postsynaptic potentials and synaptic plasticity to TCN 201 and TCN 213 in rat hippocampal slices.
Izumi Y; Zorumski CF
J Pharmacol Exp Ther; 2015 Feb; 352(2):267-73. PubMed ID: 25413830
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
